Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens

被引：0
|
作者：
Sarah M. Kashanian
Noa G. Holtzman
Ciera L. Patzke
Jonathan Cornu
Alison Duffy
Madhurima Koka
Sandrine Niyongere
Vu H. Duong
Maria R. Baer
Jummai Apata
Farin Kamangar
Ashkan Emadi
机构：
[1] University of Maryland School of Medicine,Department of Medicine
[2] National Cancer Institute,Immune Deficiency Cellular Therapy Program, Center for Cancer Research
[3] National Institutes of Health,Greenebaum Comprehensive Cancer Center
[4] University of Maryland School of Medicine,Department of Pharmacy
[5] University of Maryland Medical Center,Department of Pathology
[6] University of Maryland School of Pharmacy,Center for Urban Health Disparities Research and Innovation
[7] University of Maryland School of Medicine,Department of Biology, School of Computer, Mathematical, and Natural Sciences
[8] Morgan State University,Department of Pharmacology
[9] Morgan State University,undefined
[10] University of Maryland School of Medicine,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 87卷
关键词：
Acute lymphoblastic leukemia; Pegylated-asparaginase; Pegaspargase; ALL; Venous thromboembolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 826
页数：9
相关论文
共 50 条
  • [31] ASPARAGINASE-SPECIFIC ANTIBODY MEASUREMENT IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) UNDER NATIVE E. COLI ASPARAGINASE-BASED AND ITS POTENTIAL FACTORS ASSOCIATION
    Techavichit, Piti
    Chaweephisal, Phumin
    Poparn, Hansamon
    Chiengthong, Kanhatai
    Lauhasurayotin, Supanun
    Sosothikul, Darintr
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [32] Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL)
    Umakanthan, Jayadev Manikkam
    Maness, Lori J.
    Luo, Jiangtao
    Kallam, Avyakta
    Armitage, James O.
    Bierman, Philip
    Vose, Julie M.
    Bociek, R. Gregory
    Lunning, Matthew
    Gundabolu, Krishna
    Bhatt, Vijaya R.
    BLOOD, 2016, 128 (22)
  • [33] Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia
    Tong, Wing H.
    Mesegue, Montserrat
    Dapena, Jose Luis
    Camos, Mireia
    Rives, Susana
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 809 - 811
  • [34] Outcomes Following Discontinuation of E. coli-asparaginase upon Severe Allergic Reactions in Children with Acute Lymphoblastic Leukemia
    Liang, Der-Cherng
    Yen, Hsiu-Ju
    Chang, Wan-Hui
    Liu, Hsi-Che
    Yeh, Ting-Chi
    Hung, Giun-Yi
    Wu, Kang-Hsi
    Peng, Ching-Tien
    Chang, Yu-Hsiang
    Chang, Te-Kao
    Hsiao, Chih-Cheng
    Sheen, Jiunn-Ming
    Chao, Yu-Hua
    Chang, Tai-Tsung
    Chiou, Shyh-Shin
    Lin, Pei-Chin
    Wang, Shih-Chung
    Lin, Ming-Tsan
    Ho, Wan-Ling
    Chen, Yu-Chieh
    BLOOD, 2015, 126 (23)
  • [35] Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia
    Mall, V
    Thomas, KB
    Sauter, S
    Niemeyer, CM
    Sutor, AH
    KLINISCHE PADIATRIE, 1999, 211 (04): : 205 - 210
  • [36] A comparison of hypersensitivity reactions between intravenous and intramuscular applications of native E. coli asparaginase in children with acute lymphoblastic leukemia
    Al, Isik Odaman
    Ozdemir, Nihal
    Ersoy, Gizem Zengin
    Bayram, Cengiz
    Cilengiroglu, Ozgul Vupa
    Arslantas, Esra
    Uysalol, Ezgi Pasli
    Aycicek, Ali
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (06) : 1454 - 1460
  • [37] Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia
    Ribera, Josep-Maria
    Morgades, Mireia
    Montesinos, Pau
    Martino, Rodrigo
    Barba, Pere
    Soria, Beatriz
    Bermudez, Arancha
    Moreno, Maria-Jose
    Gonzalez-Campos, Jose
    Vives, Susana
    Gil, Cristina
    Abella, Eugenia
    Guardia, Ramon
    Martinez-Carballeira, Daniel
    Martinez-Sanchez, Pilar
    Amigo, Maria-Luz
    Mercadal, Santiago
    Serrano, Alfons
    Lopez-Martinez, Aurelio
    Vall-Llovera, Ferran
    Sanchez-Sanchez, Maria-Jose
    Penarrubia, Maria-Jesus
    Calbacho, Maria
    Mendez, Jose-Angel
    Bergua, Juan
    Cladera, Antonia
    Tormo, Mar
    Garcia-Belmonte, Daniel
    Feliu, Evarist
    Ciudad, Juana
    Orfao, Alberto
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1634 - 1643
  • [38] Efficacy and safety of PEG-asparaginase versus E. coli L-asparaginase in Chinese children with acute lymphoblastic leukemia: a meta-analysis
    Dai, Zhan-Jing
    Huang, Yan-Qin
    Lu, Yun
    TRANSLATIONAL PEDIATRICS, 2021, 10 (02) : 244 - +
  • [39] Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
    Khalil, Alaeddin
    Wuerthwein, Gudrun
    Golitsch, Jana
    Hempel, Georg
    Fobker, Manfred
    Gerss, Joachim
    Moericke, Anja
    Zimmermann, Martin
    Smisek, Petr
    Zucchetti, Massimo
    Nath, Christa
    Attarbaschi, Andishe
    von Stackelberg, Arend
    Goekbuget, Nicola
    Rizzari, Carmelo
    Conter, Valentino
    Schrappe, Martin
    Boos, Joachim
    Lanvers-Kaminsky, Claudia
    HAEMATOLOGICA, 2022, 107 (01) : 49 - 57
  • [40] Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia
    van der Sluis, Inge
    Moericke, Anja
    Escherich, Gabriele
    von Stackelberg, Arend
    Holter, Wolfgang
    Klingebiel, Thomas
    Flotho, Christian
    Legien, Sabine
    Tissing, Wim
    Bierings, Marc
    Guimbal-Schmolck, Cecile
    Pichlmeier, Uwe
    Kuehnel, Hans-Juergen
    Pieters, Rob
    HAEMATOLOGICA, 2013, 98 (11) : 1697 - 1701
12345